Detailed analysis of CD4+ Th responses to envelope and Gag proteins of simian immunodeficiency virus reveals an exclusion of broadly reactive Th epitopes from the glycosylated regions of envelope

Journal of Immunology

Volumn 168, Issue 8, 2002, Pages 4001-4011

  Sarkar, Surojit ^a   Kalia, Vandana ^a   Murphey Corb, Michael ^a   Montelaro, Ronald C ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN; EPITOPE; GAG PROTEIN; MEMBRANE PROTEIN;

ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; GLYCOSYLATION; HUMORAL IMMUNITY; IMMUNOCOMPETENT CELL; LENTIVIRINAE; MACACA; NONHUMAN; PEPTIDE MAPPING; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE;

EID: 0037090161     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.8.4001     Document Type: Article

References (48)

1. Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi
2. + lymphocytes
3. Protection of macaques against vaginal transmission of a pathogenic HIVI/SIV chimeric virus by passive infusion of neutralizing Abs
4. Neutralizing Ab directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys
5. Challenges and opportunities for development of an AIDS vaccine
6. + T cells
7. + T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: Implications for adoptive immunotherapy of virus carriers
8. HIV type 1-specific helper T cells: A critical host defense
9. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine
10. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination
11. Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans
12. Lymphocyte proliferative responses to human immunodeficiency virus antigens in vitro
13. HIV-1 peptides induce a proliferative response in lymphocytes from infected persons
14. + T cell responses associated with control of viremia
15. Characterization of HIV-1-specific T-helper cells in acute and chronic infection
16. Control of HIV despite the discontinuation of antiretroviral therapy
17. + T lymphocytes
18. HIV-1 variation diminishes CD4 T lymphocyte recognition
19. Immunization with live attenuated simian immunodeficiency virus induces strong type 1 T helper responses and β-chemokine production
20. Viremia control following antiretroviral treatment and therapeutic immunization during primary SIV251 infection of macaques
21. Containment of simian immunodeficiency virus infection: Cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatment
22. Control of SIV rebound through structured treatment interruptions during early infection
23. How B and T cells talk to each other
24. Lymphoid tissues and organs
25. Differential regulation of the Ab responses to Gag and Env proteins of human immunodeficiency virus type 1
26. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses
27. Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection
28. + T-helper proliferative responses in macaques immunized with live-attenuated SIV
29. Characterization of HIV-specific proliferative T cell responses in HIV-infected persons
30. A role for carbohydrates in immune evasion in AIDS
31. Induction of HIV-1 envelope (gp120)-specific cytotoxic T lymphocyte responses in mice by recombinant CHO cell-derived gp120 is enhanced by enzymatic removal of N-linked glycans
32. N-glycosylation of HIV-gp120 may constrain recognition by T lymphocytes
33. + T cell epitope hotspots to exposed strands of HIV envelope glycoprotein suggests structural influences on antigen processing
34. Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus
35. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene
36. Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus
37. Molecular and biological characterization of a neurovirulent molecular clone of simian immunodeficiency virus
38. Pathogenesis of simian immunodeficiency virus encephalitis: Viral determinants of neurovirulence
39. Helper T cell differentiation is controlled by the cell cycle
40. An analysis of type-C retrovirus polypeptides and their associations in the virion
41. Normal T-cell turnover in sooty mangabeys harboring active simian immunodeficiency virus infection
42. Expansion and contraction of rhesus macaque DRB regions by duplication and deletion
43. Analysis of membrane and surface protein sequences with the hydrophobic moment plot
44. Evolution of envelope-specific Ab responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity
45. T-cell antigenic sites tend to be amphipathic structures
46. Specificity of helper T-cells generated from macaques infected with attenuated simian immunodeficiency virus
47. Presentation of MUC1 tumor antigen by class 1 MHC and CTL function correlate with the glycosylation state of the protein taken up by dendritic cells
48. The mechanism of unresponsiveness to circulating tumor antigen MUC1 is a block in intracellular sorting and processing by dendritic cells